| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-10 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |